Praxis Precision Medicines
Clinical trials sponsored by Praxis Precision Medicines, explained in plain language.
A clinical-stage biopharmaceutical company developing therapies for central nervous system disorders.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Can a new daily pill tame focal seizures?
Disease control CompletedThis trial is testing whether an experimental medication called PRAX-628 can reduce the frequency of focal seizures in adults with epilepsy who are already taking one to three other seizure medications. Participants will receive either PRAX-628 or a placebo for 12 weeks, with the…
Phase: PHASE2, PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Will a tablet deliver the same dose as a capsule? a bioavailability showdown
Knowledge-focused CompletedThis trial is testing whether a new tablet form of the experimental drug PRAX-628 is absorbed by the body as well as the existing capsule form. Healthy volunteers will receive a single 40 mg dose of each version on separate occasions, and researchers will compare drug levels in t…
Phase: PHASE1 • Sponsor: Praxis Precision Medicines • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC